| A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants (NCT06682975) | Zealand Pharma | 2024-11-12 |
| Safety and Immunogenicity of V540B in Healthy Adults (V540B-002). (NCT06623409) | Merck Sharp & Dohme LLC | 2024-11-12 |
| Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies (NCT06787482) | Ace Cells Lab Limited | 2024-11-12 |
| A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration (NCT06664502) | EyeBiotech Ltd. | 2024-11-12 |
| A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease (NCT06310967) | Intelligem Therapeutics Australia Pty Ltd. | 2024-11-12 |
| Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever (NCT06684431) | Karolinska Institutet | 2024-11-12 |
| Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. (NCT06611371) | Inventprise Inc. | 2024-11-12 |
| A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes (NCT06685185) | Novo Nordisk A/S | 2024-11-12 |
| Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor (NCT07433283) | Sichuan Enray Pharmaceutical Sciences Company | 2024-11-12 |
| A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above (NCT06645665) | Shenzhen Shenxin Biotechnology Co., Ltd | 2024-11-11 |
| Single Ascending Dose Study of MSD-001 in Healthy Participants (NCT06702332) | Mindstate Design Labs | 2024-11-11 |
| A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS (NCT06714396) | QurAlis Corporation | 2024-11-11 |
| Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) (NCT06686524) | Chongqing Precision Biotech Co., Ltd | 2024-11-11 |
| Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors (NCT06646627) | Stanford University | 2024-11-11 |
| The Tatelo Plus Study (NCT06508749) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-11-11 |
| A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People (NCT06683352) | BioNTech SE | 2024-11-11 |
| A Multi-Arm, Platform Trial For Relapsed Neuroblastoma (NCT07334301) | University of Birmingham | 2024-11-11 |
| A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants (NCT06677996) | Immunome, Inc. | 2024-11-11 |
| A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer (NCT06580938) | Pfizer | 2024-11-11 |
| A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults (NCT06680375) | GlaxoSmithKline | 2024-11-11 |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study (NCT06531499) | Novartis Pharmaceuticals | 2024-11-11 |
| A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants (NCT06698926) | AbbVie | 2024-11-11 |
| Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older (NCT06686654) | Sanofi Pasteur, a Sanofi Company | 2024-11-11 |
| A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo (NCT06625177) | Teva Branded Pharmaceutical Products R&D LLC | 2024-11-11 |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease (NCT06375993) | Adicet Therapeutics | 2024-11-10 |
| Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma (NCT06674265) | Marzieh Ebrahimi | 2024-11-10 |
| PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment (NCT06157242) | Qpex Biopharma, Inc. | 2024-11-10 |
| A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting Conditions (NCT06879158) | Boryung Pharmaceutical Co., Ltd | 2024-11-10 |
| A Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Study, and QT Interval Study of HRS-5965 Capsules in Healthy Subjects (NCT06684041) | Chengdu Suncadia Medicine Co., Ltd. | 2024-11-09 |
| Study on Hibernation-like Therapy Based on Mechanical Thrombectomy (NCT06663631) | Capital Medical University | 2024-11-09 |
| The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors (NCT06911710) | Tianjin Medical University General Hospital | 2024-11-09 |
| Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers (NCT06709807) | Chong Kun Dang Pharmaceutical | 2024-11-08 |
| New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study (NCT06622434) | Assistance Publique - Hôpitaux de Paris | 2024-11-08 |
| Phase 1 Study of PRX019 in Healthy Adult Volunteers (NCT06699680) | Prothena Biosciences Ltd. | 2024-11-08 |
| Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease (NCT06606808) | University Medical Center Groningen | 2024-11-08 |
| A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease (NCT06619613) | Keymed Biosciences Co.Ltd | 2024-11-08 |
| A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation (NCT06659341) | Bayer | 2024-11-08 |
| Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT06648096) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2024-11-08 |
| A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation (NCT06667544) | Ranok Therapeutics (Hangzhou) Co., Ltd. | 2024-11-08 |
| A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body (NCT06655220) | Boehringer Ingelheim | 2024-11-08 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 in Healthy Participants (NCT06643637) | MycoMedica Life Sciences PBC | 2024-11-08 |
| Psilocybin-assisted Treatment for Cannabis Use Disorder (NCT06660381) | Johns Hopkins University | 2024-11-08 |
| A Study of LY4005130 in Healthy Participants (NCT06690996) | Eli Lilly and Company | 2024-11-08 |
| Anti-GD2 ADC M3554 in Advanced Solid Tumors (NCT06641908) | EMD Serono Research & Development Institute, Inc. | 2024-11-08 |
| A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia (NCT06483802) | Astellas Gene Therapies | 2024-11-08 |
| Study of IMC-P115C in Advanced PRAME-Positive Cancers (NCT07156136) | Immunocore Ltd | 2024-11-07 |
| Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma (NCT07093086) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2024-11-07 |
| A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer (NCT06713564) | Integro Theranostics | 2024-11-07 |
| A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) (NCT06659640) | Alnylam Pharmaceuticals | 2024-11-07 |
| A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode (NCT07549581) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2024-11-07 |
| Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) (NCT06641154) | Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare | 2024-11-06 |
| Roflumilast and TMS Motor Plasticity (NCT06457191) | University of Calgary | 2024-11-06 |
| A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia (NCT05600920) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-11-06 |
| Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers (NCT06695572) | Chong Kun Dang Pharmaceutical | 2024-11-06 |
| Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers (NCT06695598) | Chong Kun Dang Pharmaceutical | 2024-11-06 |
| Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia (NCT06447987) | City of Hope Medical Center | 2024-11-06 |
| A Study of MET233 in Individuals With Obesity or Overweight (NCT07022977) | Pfizer | 2024-11-06 |
| A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants (NCT06677957) | Genentech, Inc. | 2024-11-06 |
| A Study on the Substance Balance of [14C]XY0206 in Healthy Adult Chinese Men (NCT06823232) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2024-11-06 |
| Evaluation of K9 in Subjects With Thyroid Eye Disease (TED) (NCT06467435) | Peter Timoney | 2024-11-06 |
| Phase 1 Pharmacokinetic Study of Minoxidil SL Tablets (NCT06679556) | Samson Clinical Operations Pty Ltd | 2024-11-06 |
| Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors (NCT05629546) | Washington University School of Medicine | 2024-11-06 |
| Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate (NCT06616142) | University Medical Center Groningen | 2024-11-06 |
| Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer (NCT06479239) | University of Virginia | 2024-11-06 |
| A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers (NCT06675565) | Alnylam Pharmaceuticals | 2024-11-05 |
| Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. (NCT06663605) | Palisade Bio | 2024-11-05 |
| An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB (NCT06488924) | JCR Pharmaceuticals Co., Ltd. | 2024-11-05 |
| Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects (NCT06654960) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-11-05 |
| RHPRG4 FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE (NCT06520202) | Lubris Bio Pty Ltd | 2024-11-05 |
| Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants (NCT06647407) | Sanofi Pasteur, a Sanofi Company | 2024-11-05 |
| A Clinical Trial to Evaluate the Food Effect of CKD-379 (NCT06652971) | Chong Kun Dang Pharmaceutical | 2024-11-05 |
| FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients (NCT06564389) | Pfizer | 2024-11-05 |
| A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions (NCT06879132) | Boryung Pharmaceutical Co., Ltd | 2024-11-05 |
| Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade (NCT06794450) | Universitas Padjadjaran | 2024-11-05 |
| Food-effect Study of Ecopipam Pharmacokinetics (NCT06669091) | Emalex Biosciences Inc. | 2024-11-05 |
| Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects (NCT06658964) | Jemincare | 2024-11-05 |
| A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults (NCT06670170) | Pfizer | 2024-11-05 |
| A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation (NCT06560645) | Prelude Therapeutics | 2024-11-04 |
| Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation (NCT06668441) | Beijing Tiantan Hospital | 2024-11-04 |
| CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors (NCT06735495) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-11-04 |
| A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1) (NCT06515002) | Boehringer Ingelheim | 2024-11-04 |
| An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1). (NCT06634849) | Pathios Therapeutics Pty Ltd | 2024-11-04 |
| A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants (NCT06670950) | Synendos Therapeutics AG | 2024-11-04 |
| Trial of an Inactivated Chikungunya Virus Vaccine (NCT06669208) | Najit Technologies, Inc. | 2024-11-04 |
| Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer (NCT06691035) | H. Lee Moffitt Cancer Center and Research Institute | 2024-11-04 |
| A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) (NCT06733935) | Nkarta, Inc. | 2024-11-04 |
| Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC) (NCT07359235) | Tongji Hospital | 2024-11-04 |
| A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma (NCT06639347) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-11-04 |
| KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer (NCT06411691) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-11-04 |
| Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age (NCT06665555) | Basilea Pharmaceutica | 2024-11-04 |
| A Clinical Study of MK-1708 in Healthy Elderly Participants (MK-1708-005) (NCT06647628) | Merck Sharp & Dohme LLC | 2024-11-04 |
| A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects (NCT06641388) | Akeso | 2024-11-04 |
| A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates (NCT06632990) | Allyx Therapeutics | 2024-11-04 |
| Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02) (NCT06596694) | Merck Sharp & Dohme LLC | 2024-11-03 |
| Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia (NCT07014449) | Hangzhou Weben Pharma Co., Ltd | 2024-11-03 |
| A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants With Type 2 Diabetes Mellitus (NCT06703658) | AstraZeneca | 2024-11-02 |
| Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis (NCT06569147) | Dana-Farber Cancer Institute | 2024-11-01 |
| Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers (NCT04958772) | Megalabs | 2024-11-01 |
| ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome (NCT05116761) | Direct Biologics, LLC | 2024-11-01 |
| Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau (NCT06639503) | University of Chicago | 2024-11-01 |